OTC · INTI
Inhibitor Therapeutics, Inc.
$0.07-$0.02 (-18.75%)
Inhibitor Therapeutics, Inc.’s quoted price sits in the lower half of its reported 52-week range, 47.58% below the high.
Loading market information…
OTC · NGMDF · USD
Stock price, earnings
Quote as of Oct 28, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
NuGen Medical Devices Inc.’s quoted price sits in the lower half of its reported 52-week range, 72.3% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow NuGen Medical Devices Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
NuGen Medical Devices Inc. is a specialized firm dedicated to pioneering and marketing advanced drug delivery solutions. The company's core offering comprises innovative needle-free injection devices and systems, designed for subcutaneous medication delivery across a broad spectrum of medical conditions and therapeutic applications. These include treatments for anaphylaxis, diabetes management, severe migraine, erectile dysfunction, chronic anemia, neutropenia, and autoimmune rheumatoid arthritis, further extending to growth and fertility hormone therapies, psoriasis treatment, and various vaccine types including DNA, conventional, and pediatric formulations. Previously, the organization operated under the name BuzBuz Capital Corp., and its operational base is situated in Toronto, Canada.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 10:32 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$0.07-$0.02 (-18.75%)
Inhibitor Therapeutics, Inc.’s quoted price sits in the lower half of its reported 52-week range, 47.58% below the high.
£0.01+£0.00 (+4.0%)
CelLBxHealth plc’s quoted price sits in the lower half of its reported 52-week range, 76.79% below the high.
£0.02+£0.00 (+15.75%)
Proteome Sciences plc’s quoted price sits in the lower half of its reported 52-week range, 61.59% below the high.
CA$0.35CA$0.00 (0.0%)
Comprehensive Healthcare Systems, Inc.’s quoted price sits in the lower half of its reported 52-week range, 63.92% below the high.
$0.02-$0.00 (-8.0%)
Qscreen Ai Inc.’s quoted price sits in the lower half of its reported 52-week range, 65.67% below the high.
$0.04$0.00 (0.0%)
LianMedical’s quoted price sits in the lower half of its reported 52-week range, 75.14% below the high.
$0.06+$0.02 (+50.0%)
ADM Tronics Unlimited, Inc.’s quoted price sits in the lower half of its reported 52-week range, 50.0% below the high.
$0.01$0.00 (0.0%)
Nass Valley Gateway Ltd.: Healthcare · Medical - Distribution.
